Market Overview

Stocks Hitting 52-Week Highs

Related ARNA
CNBC's Stock Pops & Drops From January 21
Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher
Gallup Says Obesity Rates Climb Again - Can Anti-Obesity Companies Cash In? (Seeking Alpha)
Related HSIC
Top 4 NASDAQ Stocks In The Medical Equipment Wholesale Industry With The Highest ROA
UPDATE: Credit Suisse Reiterates On Henry Schein Following 3Q14 Earnings Results
Cardinal Health (CAH) Tops Q2 Earnings on Strong Revenues - Analyst Blog (Zacks)

Arena Pharmaceuticals (NASDAQ: ARNA) shares jumped 8.10% to create a new 52-week high of $9.08. The Food and Drug Administration is scheduled to make a decision on the company's experimental obesity drug lorcaserin by June 27.

Henry Schein (NASDAQ: HSIC) shares gained 1.14% to touch a new 52-week high of $78.71. Henry Schein's PEG ratio is 1.51.

Cerner (NASDAQ: CERN) shares rose 3.59% to create a new 52-week high of $85.61. Cerner and Corniche Hospital introduced the positive patient identification program to improve patient health outcomes and safety.

Smart Balance (NASDAQ: SMBL) shares gained 3.25% to create a new 52-week high of $8.26. Smart Balance shares have jumped 50.38% over the past 52 weeks, while the S&P 500 index has gained 5.61% in the same period.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers


Related Articles (ARNA + CERN)

Around the Web, We're Loving...

Get Benzinga's Newsletters